Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum

Journal of Neurochemistry

Volumn 69, Issue 3, 1997, Pages 1131-1137

  Cadogan, Anna Karina ^a   Alexander, Stephen P H ^a   Boyd, E Andrew ^b   Kendall, David A ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b Boots Sciences Building University Park   (United Kingdom)

Author keywords

Cannabinoid receptor; Cyclic AMP; Dopamine; Rat; Striatum

Indexed keywords

CANNABINOID; CYCLIC AMP;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN SLICE; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DRUG RECEPTOR BINDING; ELECTROSTIMULATION; ENZYME RELEASE; EVOKED RESPONSE; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; SECOND MESSENGER;

ANIMALIA;

EID: 0030843886     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.69031131.x     Document Type: Article

References (36)

1. Alvarez R. and Daniels D. V. (1992) Method for the assay of adenylyl cyclase, intracellular cAMP and cyclic-AMP phosphodiesterase using tritium-labelled substrates. Anal. Biochem. 203, 76-82.
2. Anderson J. J., Kask A. M., and Chase T. N. (1996) Effects of cannabinoid receptor stimulation and blockade on catalepsy produced by dopamine receptor antagonists. Eur. J. Pharmacol. 295, 163-168.
3. Anderson L. A., Anderson J. J., Chase T. N., and Walters J. R. (1995) The cannabinoid agonists WIN 55,212-2 and CP 55,940 attenuate rotational behavior induced by a dopamine D1 but not a D2 agonist in rats with unilateral lesions of the nigrostriatal pathway. Brain Res. 691, 106-114.
4. Bidaut-Russell M., Devane W. A., and Howlett A. C. (1990) Cannabinoid receptors and modulation of cyclic AMP accumulation in the rat brain. J. Neurochem. 55, 21-26.
5. Brown E., Kendall D. A., and Nahorski S. R. (1984) Inositol phospholipid hydrolysis in rat cerebral slices: I. Receptor characterisation. J. Neurochem. 42, 1379-1387.
6. Cadogan A. K., Boyd E. A., Alexander S. P. H., and Kendall D. A. (1996) Influence of cannabinoids on dopamine release and cAMP generation in the rat striatum. Br. J. Pharmacol. 119, 31P.
7. Calderon S. F., Sanberg P. R., and Norman A. B. (1988) Quinolinic acid lesions of rat striatum abolish D1 and D2-dopamine receptor-mediated catalepsy. Brain Res. 450, 403-411.
8. Caulfield M. P. and Brown D. A. (1992) Cannabinoid receptor agonists inhibit Ca current in NG 108-15 neuroblastoma cells via a pertussis toxin-sensitive mechanism. Br. J. Pharmacol. 106, 231-232.
9. Deadwyler S. A., Hampson R. E., Mu J., Whyte A., and Childers S. R. (1995) Cannabinoids modulate voltage-sensitive potassium A-current in hippocampal neurons via a cAMP-dependent process. J. Pharmacol. Exp. Ther. 273, 734-743.
10. Devane W. A., Hanus L., Breuer A., Pertwee R. G., Stevenson L. A., Griffin G., Gibson D., Mandelbaum A., Ettinger A., and Mechoulam R. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Nature 258, 1946-1949.
11. Fisher K. A., Chen K. S., Gage F. H., and Björklund A. (1991) Progressive decline in spatial learning and integrity of forebrain cholinergic neurons in rats during aging. Neurobiol. Aging 13, 9-23.
12. Fredholm B. B. (1990) Adenosine Al-receptor-mediated inhibition of evoked acetylcholine release in the rat hippocampus does not depend on protein kinase C. Acta Physiol. Scand. 140, 245-255.
13. Gifford A. N. and Ashby C. R. (1996) Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2 and is potentiated by the cannabinoid antagonist SR 141716. J. Pharmacol. Exp. Ther. 277, 1431-1436.
14. Herkenham M., Lynne A. B., Little M. D., Johnson M. R., Melvin L. S., de Costa B. R., and Rice K. C. (1990) Cannabinoid receptor localisation in brain. Proc. Natl. Acad. Sci. USA 87, 1932-1936.
15. Herkenham M., Lynne A. B., de Costa B. R., and Richfield E. K. (1991) Neuronal localisation of cannabinoid receptors in the basal ganglia of the rat. Brain Res. 547, 267-274.
16. Hollister L. E. (1986) Health aspects of cannabis. Pharmacol. Rev. 38, 1-20.
17. Howlett A. C. (1985) Cannabinoid inhibition of adenylate cyclase. Biochemistry of the response in neuroblastoma cell membranes. Mol. Pharmacol. 27, 429-436.
18. Howlett A. C., Qualy J. M., and Khachaturian L. L. (1986) Involvement of Gi in the inhibition of adenylate cyclase by cannabinoid drugs. Mol. Pharmacol. 29, 307-313.
19. Jin S., Johansson B., and Fredholm B. B. (1993) Effects of adenosine A1 and A2 receptor activation on electrically evoked dopamine and acetylcholine release from rat striatal slices. J. Pharmacol. Exp. Ther. 267, 801-808.
20. Jung M., Calassi R., Rinaldi-Carmone M., Chardenot P., Le Fur G., Soubrié P., and Oury-Donat F. (1997) Characterization of CB1 receptors on rat neuronal cell cultures: binding and functional studies using the selective receptor antagonist SR 141716. J. Neurochem. 68, 402-409.
21. Mackie K. and Hille B. (1992) Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc. Natl. Acad. Sci. USA 89, 3825-3829.
22. Mailleux P. and Vanderhaeghen J.-J. (1993) Dopaminergic regulation of cannabinoid receptor mRNA levels in the rat caudateputamen: an in situ hybridization study. J. Neurochem. 61, 1705-1712.
23. Matsuda L. A., Lolait S. J., Brownstein M. J., Young A. L., and Bonner T. I. (1990) Structure of the cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561-564.
24. Mechoulam R. (1986) The pharmacohistory of Cannabis sativa, in Cannabinoids as Therapeutic Agents (Mechoulam R., ed), pp. 1-20. CRC Press, Boca Raton, Florida.
25. Munro S., Thomas K. L., and Abu-Shaar M. (1993) Molecular characterisation of a peripheral receptor for cannabinoids. Nature 365, 61-65.
26. Nah S., Saya D., and Vogel Z. (1993) Cannabinoids inhibit agonist-stimulated formation of inositol phosphates in rat hippocampal cultures. Eur. J. Pharmacol. 246, 19-24.
27. Ogren S. O. and Fuxe K. (1988) D1 and D2-receptor antagonists induce catalepsy via different efferent striatal pathways. Neurosci. Lett. 85, 333-337.
28. Pertwee R. G., Stevenson L. A., Elrick D. B., Mechoulam R., and Corbett A. D. (1992) Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea-pig small intestine. Br. J. Pharmacol. 105, 980-984.
29. Rinaldi-Carmona M., Calandra B., Shire D., Bouaboula M., Oustric D., Barth F., Casellas P., Ferrara P., and Le Fur G. (1996a) Characterization of two cloned human CB1 cannabinoid receptor isoforms. J. Pharmacol. Exp. Ther. 278, 871-878.
30. Rinaldi-Carmona M., Pialot F., Congy C., Redon E., Barth F., Bachy A., Breliere J. C., Soubrie P., and Le Fur G. (1996b) Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain. Life Sci. 38, 1239-1247.
31. 8-tetrahydrocannabinol-dimethyl-heptyl-induced catalepsy in rats. Neuroreport 5, 761-765.
32. Romero J., Garcia L., Fernandez-Ruiz J. J., Cebeira M., and Ramos J. A. (1995) Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide or to Δ9-tetrahydrocannabinol. Pharmacol. Biochem. Behav. 51, 731-737.
33. Schlicker E., Timm J., and Göthert M. (1996) Cannabinoid receptor-mediated inhibition of dopamine release in the retina. Naunyn Schmiedebergs Arch. Pharmacol. 354, 791-795.
34. Shire D., Carillon C., Kaghad M., Calandra B., Rinaldi-Carmona M., Le Fur G., Caput D., and Ferrara P. (1995) An amino terminal variant of the central cannabinoid receptor resulting from alternative splicing. J. Biol. Chem. 270, 3726-3731.
35. Sim L. J., Selley D. E., and Childers S. R. (1995) In vitro autoradiography of receptor-activated G-proteins in rat brain by agonist-stimulated guanylyl 5′-[γ-[35S]thiol]-triphosphate binding. Proc. Natl. Acad. Sci. USA 92, 7242-7246.
36. Starke K., Gothert M., and Kilbinger H. (1989) Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol. Rev. 69, 864-889.